News and information about Novavax
This website and newsletter are not in any way sponsored, endorsed or approved by, or affiliated with Novavax, Inc. All views are solely those of our team, and do not in any way represent the views of Novavax, Inc. or its partners or employees.
This email newsletter primarily focuses on:
- The Novavax vaccine, trials, results, expert opinion, etc.
- Novavax’s business including orders, manufacturing, deliveries
- News related to Novavax’s partners around the world
- Covid and pandemic-related news
- Sometimes news about other vaccines
We scour news websites, government websites, business websites and discussion forums around the world to give you the most comprehensive information.
This newsletter is normally sent once a day with news or information we’ve found in the past day. Usually newsletters have about 1 to 5 items. If nothing noteworthy occurred in the past day, we won’t send it. In rare cases, if there is important breaking news that takes place after we’ve sent the daily newsletter, we will send a second email informing you about the breaking news.
To sign up for our email newsletter, please enter your email below. At the bottom of all emails we send you, an Unsubscribe link will be included to allow you to easily remove yourself from the list. We will not spam you, nor sell your email address.
Information or analysis in our newsletters should not be considered investment advice. By receiving the newsletter, you indemnify us from any liability that arises out of your use of the information we send.